172 related articles for article (PubMed ID: 24844281)
41. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice.
Qiu L; Qiao T; Beers M; Tan W; Wang H; Yang B; Xu Z
Mol Neurodegener; 2013 Jan; 8():1. PubMed ID: 23281774
[TBL] [Abstract][Full Text] [Related]
42. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
[TBL] [Abstract][Full Text] [Related]
43. Kif1Bbeta isoform is enriched in motor neurons but does not change in a mouse model of amyotrophic lateral sclerosis.
Conforti L; Dell'Agnello C; Calvaresi N; Tortarolo M; Giorgini A; Coleman MP; Bendotti C
J Neurosci Res; 2003 Mar; 71(5):732-9. PubMed ID: 12584731
[TBL] [Abstract][Full Text] [Related]
44. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
45. Metallothionein-III prevents neuronal death and prolongs life span in amyotrophic lateral sclerosis model mice.
Hashimoto K; Hayashi Y; Watabe K; Inuzuka T; Hozumi I
Neuroscience; 2011 Aug; 189():293-8. PubMed ID: 21640795
[TBL] [Abstract][Full Text] [Related]
46. Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats.
Zalfa C; Rota Nodari L; Vacchi E; Gelati M; Profico D; Boido M; Binda E; De Filippis L; Copetti M; Garlatti V; Daniele P; Rosati J; De Luca A; Pinos F; Cajola L; Visioli A; Mazzini L; Vercelli A; Svelto M; Vescovi AL; Ferrari D
Cell Death Dis; 2019 Apr; 10(5):345. PubMed ID: 31024007
[TBL] [Abstract][Full Text] [Related]
47. Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis.
Peviani M; Cheroni C; Troglio F; Quarto M; Pelicci G; Bendotti C
Mol Cell Neurosci; 2007 Apr; 34(4):592-602. PubMed ID: 17303436
[TBL] [Abstract][Full Text] [Related]
48. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
[TBL] [Abstract][Full Text] [Related]
49. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects.
Habisch HJ; Janowski M; Binder D; Kuzma-Kozakiewicz M; Widmann A; Habich A; Schwalenstöcker B; Hermann A; Brenner R; Lukomska B; Domanska-Janik K; Ludolph AC; Storch A
J Neural Transm (Vienna); 2007; 114(11):1395-406. PubMed ID: 17510731
[TBL] [Abstract][Full Text] [Related]
50. Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS.
Comley L; Allodi I; Nichterwitz S; Nizzardo M; Simone C; Corti S; Hedlund E
Neuroscience; 2015 Apr; 291():216-29. PubMed ID: 25697826
[TBL] [Abstract][Full Text] [Related]
51. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice.
Wu LS; Cheng WC; Shen CK
J Biol Chem; 2012 Aug; 287(33):27335-44. PubMed ID: 22718760
[TBL] [Abstract][Full Text] [Related]
52. [Restorative therapy in amyotrophic lateral sclerosis].
Aoki M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):287-92. PubMed ID: 23373317
[TBL] [Abstract][Full Text] [Related]
53. Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS.
Park JH; Park HS; Hong S; Kang S
Exp Mol Med; 2016 Dec; 48(12):e276. PubMed ID: 27932790
[TBL] [Abstract][Full Text] [Related]
54. Loss of synaptophysin-positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS.
Zang DW; Lopes EC; Cheema SS
J Neurosci Res; 2005 Mar; 79(5):694-9. PubMed ID: 15668955
[TBL] [Abstract][Full Text] [Related]
55. Mutant UBQLN2
Chen T; Huang B; Shi X; Gao L; Huang C
Acta Neuropathol Commun; 2018 Nov; 6(1):122. PubMed ID: 30409191
[TBL] [Abstract][Full Text] [Related]
56. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium.
Ferrucci M; Spalloni A; Bartalucci A; Cantafora E; Fulceri F; Nutini M; Longone P; Paparelli A; Fornai F
Neurobiol Dis; 2010 Feb; 37(2):370-83. PubMed ID: 19874893
[TBL] [Abstract][Full Text] [Related]
57. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
[TBL] [Abstract][Full Text] [Related]
58. Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis.
Forostyak S; Jendelova P; Kapcalova M; Arboleda D; Sykova E
Cytotherapy; 2011 Oct; 13(9):1036-46. PubMed ID: 21736505
[TBL] [Abstract][Full Text] [Related]
59. Genetic validation of a therapeutic target in a mouse model of ALS.
de Boer AS; Koszka K; Kiskinis E; Suzuki N; Davis-Dusenbery BN; Eggan K
Sci Transl Med; 2014 Aug; 6(248):248ra104. PubMed ID: 25100738
[TBL] [Abstract][Full Text] [Related]
60. Moderate exercise delays the motor performance decline in a transgenic model of ALS.
Carreras I; Yuruker S; Aytan N; Hossain L; Choi JK; Jenkins BG; Kowall NW; Dedeoglu A
Brain Res; 2010 Feb; 1313():192-201. PubMed ID: 19968977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
